(Circulation. 2001;103:102.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Effect of Type 2 Diabetes Mellitus on Left Ventricular Geometry and Systolic Function in Hypertensive Subjects
Hypertension Genetic Epidemiology Network (HyperGEN) Study
From the Weill Medical College of Cornell University (V.P., J.N.B., J.E.L., M.-Y.S., R.B.D.), New York, NY; University of Minnesota (D.K.A.), Minneapolis, Minn; University of Alabama at Birmingham (A.O.), Birmingham, Ala; Wake Forest University School of Medicine (D.W.K.), Winston-Salem, NC; University of Utah School of Medicine (P.N.H.), Salt Lake City, Utah; and Washington University Medical School (D.M., D.C.R.), St. Louis, Mo.
Correspondence to Vittorio Palmieri, MD, Weill Medical College of Cornell University, Division of Cardiology (Box 222), 525 E 68th Street, New York, NY 10021. E-mail: vpalmier{at}med.cornell.edu
Background—Type 2 diabetes is a cardiovascular risk factor. It remains to be elucidated in a large, population-based sample whether diabetes is associated with changes in left ventricular (LV) structure and systolic function independent of obesity and systolic blood pressure (BP).
Methods and Results—Among 1950 hypertensive participants in the HyperGEN Study without overt coronary heart disease or significant valve disease, 20% (n=386) had diabetes. Diabetics were more likely to be women, black, older, and have higher BMI and waist/hip ratio than were nondiabetics. After adjustment for age and sex, diabetics had higher systolic BP, pulse pressure, and heart rate; lower diastolic BP; and longer duration of hypertension than nondiabetics. LV mass and relative wall thickness were higher in diabetic than nondiabetic subjects independent of covariates. Compared with nondiabetic hypertensives, diabetics had lower stress-corrected midwall shortening, independent of covariates, without difference in LV EF. Insulin levels and insulin resistance were higher in non–insulin-treated diabetics (n=195) than nondiabetic (n=1439) subjects (both P<0.01). Insulin resistance positively but weakly related to LV mass and relative wall thickness.
Conclusions—In a relatively healthy, population-based sample of hypertensive adults, type 2 diabetes was associated with higher LV mass, more concentric LV geometry, and lower myocardial function, independent of age, sex, body size, and arterial BP. structural and functional abnormalities in addition to, and independent of, atherosclerosis.13 14 In the Framingham cohort, diabetes was associated with higher LV mass in women but not men.15 High blood pressure (BP), obesity, and abnormal lipid profile, which often coexist with diabetes, tend to be associated with preclinical cardiovascular abnormalities16 and may contribute to the association of diabetes with cardiovascular events. Cardiac features of diabetic and nondiabetic hypertensive subjects remain incompletely described in population-based samples. Therefore, we compared clinical and metabolic characteristics, LV geometry, and systolic function between diabetic and nondiabetic hypertensive participants in the Hypertension Genetic Epidemiology Network (HyperGEN) Study.
This article has been cited by other articles:
 |
|
 |
|
  E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Bella, W. Tang, A. Kraja, D. C. Rao, S. C. Hunt, M. B. Miller, V. Palmieri, M. J. Roman, D. W. Kitzman, A. Oberman, et al. Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships: The Hypertension Genetic Epidemiology Network Study Hypertension, March 1, 2007; 49(3): 453 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Galderisi Diastolic Dysfunction and Diabetic Cardiomyopathy: Evaluation by Doppler Echocardiography J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1548 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Palmieri, C. Russo, E. Arezzi, S. Pezzullo, M. Sabatella, S. Minichiello, and A. Celentano Relations of longitudinal left ventricular systolic function to left ventricular mass, load, and Doppler stroke volume Eur J Echocardiogr, October 1, 2006; 7(5): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guazzi, S. Belletti, E. Bianco, L. Lenatti, and M. D. Guazzi Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H921 - H928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schillaci, M. Pirro, G. Pucci, M. R. Mannarino, F. Gemelli, D. Siepi, G. Vaudo, and E. Mannarino Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women Hypertension, May 1, 2006; 47(5): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Okin, R. B. Devereux, E. Gerdts, S. M. Snapinn, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, L. H. Lindholm, et al. Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Circulation, March 28, 2006; 113(12): 1588 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sato, L. Tarnow, F.S. Nielsen, E. Knudsen, and H.-H. Parving Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment QJM, December 1, 2005; 98(12): 879 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Rasmussen-Torvik, K. E. North, C. C. Gu, C. E. Lewis, J. B. Wilk, A. Chakravarti, Y.-P. C. Chang, M. B. Miller, N. Li, R. B. Devereux, et al. A Population Association Study of Angiotensinogen Polymorphisms and Haplotypes With Left Ventricular Phenotypes Hypertension, December 1, 2005; 46(6): 1294 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Burchfiel, T. N. Skelton, M. E. Andrew, R. J. Garrison, D. K. Arnett, D. W. Jones, and H. A. Taylor Jr Metabolic Syndrome and Echocardiographic Left Ventricular Mass in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, August 9, 2005; 112(6): 819 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. de Simone, D. W. Kitzman, M. Chinali, A. Oberman, P. N. Hopkins, D. C. Rao, D. K. Arnett, and R. B. Devereux Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study Eur. Heart J., May 2, 2005; 26(10): 1039 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. de Simone, R. B Devereux, J. R Kizer, M. Chinali, J. N Bella, A. Oberman, D. W Kitzman, P. N Hopkins, D. Rao, and D. K Arnett Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study Am. J. Clinical Nutrition, April 1, 2005; 81(4): 757 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lindahl, J. Lindback, T. Jernberg, N. Johnston, M. Stridsberg, P. Venge, and L. Wallentin Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: A Fragmin and fast Revascularisation during InStability in coronary artery disease (FRISC)-II substudy J. Am. Coll. Cardiol., February 15, 2005; 45(4): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Devereux, K. Wachtell, E. Gerdts, K. Boman, M. S. Nieminen, V. Papademetriou, J. Rokkedal, K. Harris, P. Aurup, and B. Dahlof Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension JAMA, November 17, 2004; 292(19): 2350 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Devereux, B. Dahlof, E. Gerdts, K. Boman, M. S. Nieminen, V. Papademetriou, J. Rokkedal, K. E. Harris, J. M. Edelman, and K. Wachtell Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial Circulation, September 14, 2004; 110(11): 1456 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Magnusson, O. Melander, B. Israelsson, A. Grubb, L. Groop, and S. Jovinge Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease Diabetes Care, August 1, 2004; 27(8): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rinder, R. J. Spina, L. R. Peterson, C. J. Koenig, C. R. Florence, and A. A. Ehsani Comparison of effects of exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive adults Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R360 - R368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Klapholz, M. Maurer, A. M. Lowe, F. Messineo, J. S. Meisner, J. Mitchell, J. Kalman, R. A. Phillips, R. Steingart, E. J. Brown Jr, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1432 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M.A. Henry, O. Kamp, P. J. Kostense, A. M.W. Spijkerman, J. M. Dekker, R. van Eijck, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer Left Ventricular Mass Increases With Deteriorating Glucose Tolerance, Especially in Women: Independence of Increased Arterial Stiffness or Decreased Flow-Mediated Dilation: The Hoorn Study Diabetes Care, February 1, 2004; 27(2): 522 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Andersen, S. H. Poulsen, K. Helleberg, P. Ivarsen, S. T. Knudsen, and C. E. Mogensen Impact of Essential Hypertension and Diabetes Mellitus on Left Ventricular Systolic and Diastolic Performance Eur J Echocardiogr, December 1, 2003; 4(4): 306 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Palmieri, R. P. Tracy, M. J. Roman, J. E. Liu, L. G. Best, J. N. Bella, D. C. Robbins, B. V. Howard, and R. B. Devereux Relation of Left Ventricular Hypertrophy to Inflammation and Albuminuria in Adults With Type 2 Diabetes: The Strong Heart Study Diabetes Care, October 1, 2003; 26(10): 2764 - 2769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vaur, P. Gueret, M. Lievre, S. Chabaud, and P. Passa Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study Diabetes Care, March 1, 2003; 26(3): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Rutter, H. Parise, E. J. Benjamin, D. Levy, M. G. Larson, J. B. Meigs, R. W. Nesto, P. W.F. Wilson, and R. S. Vasan Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study Circulation, January 28, 2003; 107(3): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Palmieri, P. M. Okin, J. N. Bella, E. Gerdts, K. Wachtell, J. Gardin, V. Papademetriou, M. S. Nieminen, B. Dahlof, and R. B. Devereux Echocardiographic Wall Motion Abnormalities in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study Hypertension, January 1, 2003; 41(1): 75 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Solomon, M. S. J. Sutton, G. A. Lamas, T. Plappert, J. L. Rouleau, H. Skali, L. Moye, E. Braunwald, M. A. Pfeffer, and for the Survival And Ventricular Enlargement (SAVE Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction Circulation, September 3, 2002; 106(10): 1251 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tang, D. K. Arnett, R. B. Devereux, M. A. Province, L. D. Atwood, A. Oberman, P. N. Hopkins, and D. W. Kitzman Sibling Resemblance for Left Ventricular Structure, Contractility, and Diastolic Filling Hypertension, September 1, 2002; 40(3): 233 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, W. E. Mitch, R. W. Nesto, P. T. O'Gara, R. C. Becker, L. T. Clark, S. Hunt, I. Jialal, S. E. Lipshultz, and E. Loh Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications Circulation, May 7, 2002; 105 (18): e159 - e164. [Full Text] [PDF]
|
|
|
|
|
|
P.W. Serruys ARTS I--the rapamycin eluting stent; ARTS II--the rosy prophecy Eur. Heart J., May 2, 2002; 23(10): 757 - 759. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Devereux, J. N. Bella, V. Palmieri, A. Oberman, D. W. Kitzman, P. N. Hopkins, D.C. Rao, D. Morgan, M. Paranicas, D. Fishman, et al. Left Ventricular Systolic Dysfunction in a Biracial Sample of Hypertensive Adults: The HyperGEN Study Hypertension, September 1, 2001; 38(3): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Bella, V. Palmieri, J. E. Liu, D. W. Kitzman, A. Oberman, S. C. Hunt, P. N. Hopkins, D.C. Rao, D. K. Arnett, and R. B. Devereux Relationship Between Left Ventricular Diastolic Relaxation and Systolic Function in Hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN) Study Hypertension, September 1, 2001; 38(3): 424 - 428. [Abstract] [Full Text] [PDF]
|
|